Zoetis ZTS
NYSE ZTS
$73.31 -0.25 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Zoetis (ZTS) Cash from Operations Growth (3y) (2015 - 2026)

Analysis

Zoetis (ZTS) Cash from Operations Growth (3y) (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn 20.12%
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn 52.97%
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn 65.60%
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn 5.99%
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn -
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -113.87%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.97%
Mar 31, 2026 -9.94%
Dec 31, 2025 6.42%
Sep 30, 2025 19.21%
Jun 30, 2025 21.66%
Mar 31, 2025 18.56%
Dec 31, 2024 10.05%
Sep 30, 2024 13.35%
Jun 30, 2024 1.43%
Mar 31, 2024 14.15%
Dec 31, 2023 7.70%
Sep 30, 2023 8.81%
Jun 30, 2023 -25.24%
Mar 31, 2023 10.40%
Dec 31, 2022 8.38%
Sep 30, 2022 1.30%
Jun 30, 2022 1.85%
Mar 31, 2022 -7.39%
Dec 31, 2021 5.15%
Sep 30, 2021 5.89%